The companies will also continue joint product development activities ensuring customers have continued access to new coagulation technology.
“Our shared value to deliver quality products and services that address our customers’ needs is a key contributor to the success of our 14-year partnership,” said Donal Quinn, chief executive officer (CEO), Siemens Healthcare Diagnostics. “Together, we expect to not only offer customers the broad portfolio of coagulation products they have come to expect from us today, but also to deliver next-generation technology in the future.”
“We are pleased to continue our long-standing relationship with Siemens Healthcare,” said Hisashi Ietsugu, president & CEO, Sysmex. “Our partnership combines the strengths of two leading diagnostic companies whose joint expertise offers best-in-class solutions for the laboratory, and we look forward to expanding the clinical utility of these solutions cooperatively.”